Evaluation of endoscopic retrograde cholangiopancreatography procedures performed in general hospitals in France

Gastroenterologie Clinique et Biologique

Volumn 31, Issue 8-9 C1, 2007, Pages 740-749

  Vitte, René Louis ^a   Morfoisse, Jean Jacques ^b   Courrier, A ^c   Benghanem, M ^c   Favriel, J M ^c   Duchmann, J C ^c   Glibert, A ^c   Morin, T ^c   Druart, F ^c   Pariente, A ^c   Berthelemy P ^c   Arotarena, R ^c   Capony, P ^c   Bour, B ^c   Blanchi, A ^c   Ramain, J P ^c   Gargot, D ^c   Arpurt, J P ^c   Bellon, S ^c   Cervoni, J P ^c   Reville M ^c   Zirabe, S ^c   Pillon, D ^c   Nalet, B ^c   Gury, B ^c   Moindrot, H ^c   Waton, M ^c   Combes, R ^c   Soupison, A ^c   Gatineau Saillant, G ^c   Bordes, G ^c   Grasset, D ^c   Rifflet, H ^c   Abdelli, N ^c   Louvel, D ^c   Verger, P ^c   Tabet, M ^c   Seyrig, J A ^c   Gineston, J L ^c   more..

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^b Centre Hospitalier de Montauban   (France)

^c Centre Hospitalier Intercommunal de Poissy ^*

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLEEDING; CHOLANGITIS; CHOLECYSTITIS; CLINICAL EVALUATION; CLINICAL TRIAL; COMMON BILE DUCT; CORRELATION FUNCTION; DEATH; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FRANCE; GENERAL HOSPITAL; HUMAN; INTESTINE PERFORATION; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; PANCREATITIS; PROSPECTIVE STUDY; RISK; SCORING SYSTEM;

EID: 34948826912     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(07)91936-3     Document Type: Article

References (33)

1. Demling L, Koch H, Classen M, Belohlavek D, Schaffner O, Schwamberger K, et al. Endoscopic papillotomy and removal of gallstones: animal experiments and first clinical results. Dtsch Med Wochenschr 1974;99:2255-7.
2. Société Nationale Française de Gastro- Entérologie. Le livre blanc de l'Hépato-Gastro-entérologie, juin 2001.
3. Barthet M, Heyries L, Desjeux A. Complications à court terme de la cholangio-pancréatographie rétrograde endoscopique (CPRE) diagnostique et thérapeutique. Gastroenterol Clin Biol 2002;26:980-7.
4. Freeman ML. Adverse outcomes of ERCP. Gastrointestinal Endosc 2002;56:S273-S282.
5. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-18.
6. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10.
7. Barthet M, Lesavre N, Desjeux A, Gasmi M, Berthezene P, Berdah S, et al. Complications of endoscopic sphincterotomy: results from a single tertiary referral center. Endoscopy 2002;34:991-7.
8. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-93.
9. Makary MA, Duncan MD, Harmon JW, Freeswick PD, Bender JS, Bohlman M, et al. The role of magnetic resonance cholangiography in the management of patients with gallstone pancreatitis. Ann Surg 2005;241:119-24.
10. Aube C, Delorme B, Yzet T, Burtin P, Lebigot J, Pessaux P, et al. MR cholangiopancreatography versus endoscopic sonography in suspected common bile duct lithiasis: a prospective, comparative study. Am J Roentgenol 2005;184:55-62.
11. Vandervoort J, Soetikno RM, Tham TCK, Wong RCK, Ferrari AP, Montes H, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002;56:652-6.
12. Farrell RJ, Mahmud N, Noonan N, Kelleher D, Keeling PW. Diagnostic and therapeutic ERCP: a large single centre's experience. Ir J Med Sci 2001;170:176-80.
13. Christensen M, Matzen P, Schulze S, Rosenberg J. Complications of ERCP: a prospective study. Gastroenterol Endosc 2004;60:721-31.
14. Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001;96:417-23.
15. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy - Italian Group. N Engl J Med 1996;335:919-23.
16. Andriulli A, Leandro G, Niro G, Mangia A, Festa V, Gambassi G, et al. Pharmacologic treatment can prevent pancreatic injury after ER-CP: a meta-analysis. Gastrointest Endosc 2000;51:1-7.
17. Deviere J, Le Moine O, Van Laethem JL, Eisendrath P, Ghilain A, Severs N, et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001;120:498-505.
18. Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998;115:1518-24.
19. Baron TH, Harewood GC. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am J Gastroenterol 2004;99:1455-60.
20. Ong TZ, Khor JL, Selamat DS, Yeoh KG, Ho KY. Complications of endoscopic retrograde cholangiographie in the post-MRCP era: a tertiary center experience. World J Gastroenterol 2005;11:5209-12.
21. Baron TH, Petersen BT, Mergener K, Chak A, Cohen J, Deal SE, et al. Quality indicators for endoscopic retrograde cholangiopancreatography. Am J Gastroenterol 2006;101:892-7.
22. Suissa A, Yassin K, Lavy A, Lachter J, Chermech I, Karban A, et al. Outcome and early complications of ERCP: a prospective single center study. Hepatogastroenterology 2005;52:352-5.
23. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001;54:425-34.
24. Rabenstein T, Schneider HT, Bulling D, Nicklas M, Katalinic A, Hahn EG, et al. Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment. Endoscopy 2000;32:10-9.
25. Aronson N, Flamm CR, Bohn RL, Mark DH, Speroff T. Evidence-based assessment: patient, procedure, or operator factors associated with ERCP complications. Gastrointest Endosc 2002;56:S294-S302.
26. COLOR Study Group. Impact of hospital case volume on short-term outcome after laparoscopic operation for colonic cancer. Surg Endosc 2005;19:687-92.
27. Schrag D, Panageas KS, Riedel E, Hsieh L, Bach PB, Guillem JG, et al. Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol 2003;83:68-78.
28. Finlayson EV, Birkmeyer JD. Effects of hospital volume on life expectancy after selected cancer operations in older adults: a decision analysis. J Am Coll Surg 2003;196:410-7.
29. Ko CY, Chang JT, Chaudhry S, Kominski G. Are high-volume surgeons and hospitals the most important predictors of in-hospital outcome for colon cancer resection? Surgery 2002;132:268-73.
30. Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann Surg 1998;227:157-67.
31. Sosa JA, Bowman HM, Gordon TA, Bass EB, Yeo CJ, Lillemoe KD, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 1998;228:429-38.
32. Subhani JM, Kibbler C, Dooley JS. Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther 1999;13:103-16.
33. Harris A, Chan AC, Torres-Viera C, Hammett R, Carr-Locke D. Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 1999;31:718-24.